Description
Ayşe Güven studied Molecular Biology and Genetics in Turkey and moved to Dresden in 2012 for her PhD studies. During her time in Dresden, she studied evolution and development of the mammalian brain and obtained her PhD from MPI-CBG in 2016. After spending a long time in basic research, she joined Alcimed as a business and innovation consultant and she is currently based in Cologne.
In her role at Alcimed, she is providing external support to projects spanning whole product value chain of various companies from biotech, pharmaceutical, and healthcare industries. Her clients include decision makers from Roche, Merck, Bayer, Siemens Healthineers, as well as others.